The patient-specific nature of autologous cell therapies presents unique challenges that can best be addressed by a middle path between on-site and centralized manufacturing.

Cell-based chimeric antigen receptor (CAR) T cell therapies have rapidly advanced in recent years, with a variety of targets in clinical research and several FDA approved products already on the ...

Researchers from Osaka University report say they have developed an automated modular system for aseptic stem cell manufacturing. Masahiro Kino-oka, PhD, professor of biotechnology and director of the ...

Made Scientific, a leading U.S.-based cell therapy contract development and manufacturing organization (CDMO), and Basilard BioTech, a Southern California biotechnology company pioneering novel ...

The technology is designed to improve patient accessibility to cell therapies by improving manufacturing efficiency.

As the cell therapy industry continues to grow, it must face the challenge of creating products that are not only safe and effective, but also affordable. Currently, the prices for approved products ...

Cellular Origins, a TTP Company focused on enabling scalable, cost-effective, and efficient manufacture of cell and gene therapies (CGTs), has today announced a collaborative partnership with ...

UK-based Cellular Agriculture Ltd has announced a series of developments that advance its position as a technology provider ...

So far, rigid production processes and product lines have characterized battery production for various applications, from e-mobility to the power tool. The AgiloBat research project will facilitate a ...